Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2024 07:57 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention

To learn more about ZyVersa's Inflammasome ASC Inhibitor and Renal Pipelines, schedule a one-on-one meeting on 2024 BIO International Conference's Portal.
June 01, 2023 08:00 ET | Source: Elevar Therapeutics

Elevar Therapeutics to Participate in ASCO 2023 and BIO 2023; New Jersey-based Company Secures State License as It Builds Toward Commercialization

FORT LEE, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
May 16, 2023 08:00 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Participating at 2023 BIO International Convention

AGOURA HILLS, Calif., May 16, 2023 (GLOBE NEWSWIRE) -- Oncotelic Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), a pioneering developer of therapeutic interventions for rare and orphan diseases...
June 15, 2022 07:00 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Provides Update on OT-101 at the 2022 BIO International Convention

AGOURA HILLS, Calif., June 15, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
June 14, 2022 09:00 ET | Source: Qualigen Therapeutics, Inc.

Qualigen Therapeutics to Present at BIO International Convention

CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers...
May 18, 2022 08:00 ET | Source: Oncotelic Therapeutics, Inc.

Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention

AGOURA HILLS, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), developer of treatments for rare and orphan indications, including...
June 05, 2019 12:15 ET | Source: Syneos Health, Inc.

Syneos Health Consulting Releases 11th Annual Survey of Biopharmaceutical Dealmakers

PHILADELPHIA, June 05, 2019 (GLOBE NEWSWIRE) -- The 11th annual Dealmakers’ Intentions Study from Syneos Health Consulting, an industry-leading biopharmaceutical management consulting firm,...
June 05, 2018 08:55 ET | Source: Syneos Health

Syneos Health to Present Actionable Commercial Insights Designed for Biopharmaceutical Companies at BIO International Convention

RALEIGH, N.C., June 05, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and...
June 16, 2014 16:53 ET | Source: European American Enterprise Council

Top European Biotech, Pharma Executives Gathering to Discuss San Diego Strategic Business Partnerships

SAN DIEGO, CA--(Marketwired - Jun 16, 2014) - Senior executives from leading European biotech and pharma companies will discuss how public and private sector organizations in San Diego can best...
April 19, 2013 13:00 ET | Source: Avid Bioservices

Avid Bioservices to Present a Case Study on cGMP Production Scale-Up, Optimization and Transition From a Stainless Steel to a Fully Disposable Process at BIO International Convention

TUSTIN, CA--(Marketwired - Apr 19, 2013) - Avid Bioservices, Inc., a subsidiary of Peregrine Pharmaceuticals, Inc., today announced its upcoming participation at the Biotechnology Industry...